April 2, 2007 - 4: Statement of changes in beneficial ownership of securities

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Reich Samuel J

2. Issuer Name and Ticker or Trading Symbol
eXegenics Inc [EXEG]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Executive VP

(Last)

(First)

(Middle)

EXEGENICS INC., 4400 BISCAYNE BOULEVATD, SUITE 900

3. Date of Earliest Transaction (Month/Day/Year)
03/29/2007

(Street)

MIAMI, FL 33137

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/29/2007		J⁽¹⁾		490,921	A	$ 0	490,021	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Warrant (Right to Buy)

$ 0.6728

03/29/2007

J⁽¹⁾

14,883

⁽²⁾

03/27/2017

Common Stock

14,883

$ 0

14,883

Warrant (Right to Buy)

$ 0.8473

03/29/2007

J⁽¹⁾

14,883

⁽²⁾

03/27/2017

Common Stock

14,883

$ 0

14,883

Warrant (Right to Buy)

$ 1.0466

03/29/2007

J⁽¹⁾

14,883

⁽²⁾

03/27/2017

Common Stock

14,883

$ 0

14,883

Stock Option (Right to Buy)

$ 0.04

03/29/2007

J⁽¹⁾

259,471

⁽³⁾

12/11/2013

Common Stock

259,471

$ 0

259,471

Stock Option (Right to Buy)

$ 0.04

03/29/2007

J⁽¹⁾

233,524

⁽⁴⁾

09/21/2014

Common Stock

233,524

$ 0

233,524

Stock Option (Right to Buy)

$ 0.04

03/29/2007

J⁽¹⁾

456,669

⁽⁵⁾

02/15/2015

Common Stock

456,669

$ 0

456,669

Stock Option (Right to Buy)

$ 0.05

03/29/2007

J⁽¹⁾

287,686

⁽⁶⁾

11/01/2015

Common Stock

287,686

$ 0

287,686

Stock Option (Right to Buy)

$ 0.05

03/29/2007

J⁽¹⁾

287,686

⁽⁷⁾

01/01/2016

Common Stock

287,686

$ 0

287,686

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Reich Samuel J EXEGENICS INC. 4400 BISCAYNE BOULEVATD, SUITE 900 MIAMI, FL 33137			Executive VP

Signatures

/s/ Samuel J. Reich		03/30/2007
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	All securities described were acquired in a merger transaction between Acuity Pharmaceuticals Inc. and eXegenics Inc.
(2)	There warrants are currently exercisable.
(3)	210,800 of these options are presently fully vested. The balance will vest monthly until fully vested in December 2007.
(4)	145,950 of these options are presently fully vested. The balance will vest monthly until fully vested in September 2008.
(5)	237,847 of these options are presently fully vested. The balance will vest monthly until fully vested in February 2009.
(6)	95,894 of these options are presently fully vested. The balance will vest monthly until fully vested in November 2009.
(7)	83,905 of these options are presently fully vested. The balance will vest monthly until fully vested in January 2010.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.